• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2005 Fiscal Year Final Research Report Summary

Development of model mice of adult T-cell leukemia for evaluation of new therapeutic agents

Research Project

Project/Area Number 15500300
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Laboratory animal science
Research InstitutionKumamoto University

Principal Investigator

OHSUGI Takeo  Kumamoto University, Institute of Resource Development and Analysis, Associate professor, 生命資源研究・支援センター, 助教授 (00211102)

Co-Investigator(Kenkyū-buntansha) WATANABE Toshiki  Tokyo University, The Institute of Medical Science, Professor, 医科学研究所, 教授 (30182934)
URANO Toru  Kumamoto University, Institute of Resource Development and Analysis, Professor, 生命資源研究・支援センター, 教授 (90101899)
Project Period (FY) 2003 – 2005
KeywordsHTLV-I / ATL / mice / SCID mice / animal model
Research Abstract

We established small-animal models that is appropriate to assess therapeutic agents for adult T-cell leukemia (ATL).
1.SCID mice model
We developed an improved severe combined immunodeficiency (SCID) mouse model for ATL. Five-week-old SCID mice in which natural killer (NK) cell activity had been eliminated were inoculated intraperitoneally with the HTLV-I-infected cell lines, TL-Om1, MT-1, MT-2 and HUT-102. No engraftment of TL-Om1 cells and little tumorigenesis of MT-1 cells were detected 40 days after injection. In contrast, inoculation of mice with MT-2 and HUT-102 cells elicited high mortality, 100% frequency of gross tumor formation, and tumor cell infiltration of various organs, all of which were reduced by co-administration of DHMEQ during the inoculation. Moreover, tumors from mice treated with DHMEQ had a high frequency of apoptosis. These results suggest that DHMEQ induces apoptosis in HTLV-I-transformed cells in vivo, resulting in inhibition of tumor formation and organ infilt … More ration, thereby enhancing survival.
2.HTLV-I Tax transgenic mice
Tax gene product of HTLV-I encoded may be responsible for the development of diseases caused by this virus. We established a series of novel transgenic mice carrying the tax gene under the control of a mice lymphocyte-specific protein tyrosine kinase (p56lck) proximal or distal promoter. Several lines of Lck-proximal-tax mice showed dermatitis, however we did not demonstrate the expression of Tax in these lesions. The mice expressing Tax controlled by Lck distal promoter in mature thymocytes and peripheral T lymphocytes developed T-cell lymphoma and leukemia. The mice showed the development of marked splenomegaly, hepatomegaly and lymphadenopathy. Histological examination showed diffuse, large-cell lymphomas involving spleen, lymph nodes, liver, thymus, bone marrow, kidney, lung, meninges and skin. Blood smears showed the presence of large and abnormal leukemic cells. The malignant phenotype observed in the transgenic mice was CD4+ or CD8+. This is the first report that transgenic model of Tax expression resulted in the development of mature T-cell lymphoma. Less

  • Research Products

    (13 results)

All 2006 2005 2004 2003

All Journal Article (13 results)

  • [Journal Article] In vitro and in vivo antitumor activity of the NF-κB inhibitor DHMEQ in the human T-cell leukemia virus type I-infected cell line,HUT-102.2006

    • Author(s)
      Ohsugi, T. et al.
    • Journal Title

      Leukemia Res 30

      Pages: 90-97

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Activation of a cryptic splice site in the tax gene of HTLV-I by a single nucleotide change.2006

    • Author(s)
      Ohsugi, T.
    • Journal Title

      Biochimie 88

      Pages: 147-150

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] In vitro and in vivo antitumor activity of the NF-κB inhibitor DHMEQ in the human T-cell leukemia virus type I-infected cell line, HUT-102.2006

    • Author(s)
      Ohsugi T et al.
    • Journal Title

      Leukemia Res. 30

      Pages: 90-97

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] In vivo antitumor activity of the NF-kB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia.2005

    • Author(s)
      Ohsugi, T. et al.
    • Journal Title

      Carcinogenesis 26

      Pages: 1382-1388

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Dual targeting of transformed and untransformed HTLV-1-infected T-cells by DHMEQ,a potent and selective inhibitor of NF-kB,as a strategy for chemoprevention and therapy of adult T cell2005

    • Author(s)
      Watanabe, M., Ohsugi, T., Shoda, M., et al.
    • Journal Title

      Blood 106

      Pages: 2462-2471

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] In vivo antitumor activity of the NF-kB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia.2005

    • Author(s)
      Ohsugi T et al.
    • Journal Title

      Carcinogenesis 26

      Pages: 1382-1388

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Dual targeting of transformed and untransformed HTLV-1-infected T-cells by DHMEQ, a potent and selective inhibitor of NF-kB, as a strategy for chemoprevention and therapy of adult T cell leukemia.2005

    • Author(s)
      Watanabe M, Ohsugi T, Shoda M et al.
    • Journal Title

      Blood 106

      Pages: 2462-2471

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Rapid tumor death model for evaluation of new therapeutic agents for Adult T-cell Leukemia2004

    • Author(s)
      Ohsugi, T. et al.
    • Journal Title

      Lab.Invest 84

      Pages: 263-266

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Construction of a full-length human T cell leukemia virus type I(HTLV-I) genome from MT-2 cells containing multiple defective proviruses using overlapping polymerase chain reaction2004

    • Author(s)
      Ohsugi, T., Kumasaka, T., Urano, T.
    • Journal Title

      Anal.Biochem. 329

      Pages: 281-288

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Rapid tumor death model for evaluation of new therapeutic agents for Adult T-cell Leukemia.2004

    • Author(s)
      Ohsugi T et al.
    • Journal Title

      Lab.Invest. 84

      Pages: 263-266

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Construction of a full-length human T cell leukemia virus type I (HTLV-I) genome from MT-2 cells containing multiple defective proviruses using overlapping polymerase chain reaction.2004

    • Author(s)
      Ohsugi T et al.
    • Journal Title

      Anal.Biochem. 329

      Pages: 281-288

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] 重症複合免疫不全(SCID)マウスを用いた成人T細胞白血病(ATL)モデル作製における加齢の影響2003

    • Author(s)
      大杉剛生ら
    • Journal Title

      九州実験動物雑誌 19

      Pages: 25-29

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Effect of age on production of animal model for adult T-cell leukemia in severe combined immunodeficiency mice.2003

    • Author(s)
      Ohsugi T.et al.
    • Journal Title

      Kyusyu J.Exp.Anim.(in Japanese) 20

      Pages: 25-29

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2007-12-13  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi